Neurodiagnostics Market By Application (In Vitro Diagnostics, Neuroinformatics, Neuroimaging) - Industry Size, Growth, Share And Forecast To 2026
The global Neurodiagnostics market is anticipated to grow with a CAGR of around 7% during the forecast period (2019-2026). The major factors driving the global market are rising geriatric population, increasing adoption of novel diagnostic technologies, increasing prevalence of neurological diseases. In addition, increasing Patient Base in developing Economies, innovative product development is acting as the key growth opportunities of the global market. Moreover, there has been increasing prevalence of neurological diseases such as Alzheimer’s disease, migraine, Parkinson’s, epilepsy, stroke, multiple sclerosis, neurodegeneration etc. which has led to increased adoption of Neurodiagnostic technologies for diagnosis and treatment of neurological diseases. According to World Health Organization (WHO), approximately 6 million deaths occur due to stroke each year. Furthermore, as per WHO, epilepsy is a common neurological disease and approximately 50 million people (as in 2016) globally suffer from epilepsy and 2.4 million people are diagnosed with epilepsy each year. Moreover, as per WHO, Alzheimer’s disease has led to 7.7 million new cases of dementia every year. Further, according to the Reliant Medical Group Central Massachusetts Healthcare (United States), neurological disorders such as strokes, neuropathy, Alzheimer, etc. are highly prevalent among geriatric population (more than 65 years of age) as these diseases preferentially affect the central nervous system. According to the alliance for aging research, in 2017, there were around 64,000 novel incidences of Alzheimer’s in Americans ages 65 – 74, and 243,000 new cases in those 85+ age and around 173,000 new cases for 75-84. Every 70 seconds, someone in the U.S. develops Alzheimer’s disease. 16% of women age 71 and older have Alzheimer’s disease or other dementias compared with 11% of men.
Based on segmentation, the global market is segmented into Neurodiagnostic technologies market. the technologies segment is further sub segmented into In-Vitro Diagnostics, Neuroimaging and Neuroinformatic. Further, Neuroimaging is further divided into Magnetic Resonance Imaging, Computed Tomography, Near Infrared Spectroscopic Imaging, Nuclear Medicine Imaging, Electroencephalography, Voxel-based Morphometry and Magnetoencephalography.
Based on geography, based on geography, the global Neurodiagnostic market is segmented into North America, Europe, Asia pacific, and Row. North America is expected to have the largest share of the market over the period of 2019-2026. The North America Neurodiagnostic market is mainly driven owing to the increasing geriatric population considering escalating cases of Alzheimer’s and Parkinson’s disease which occurs most in the old aged individuals along with investments made by the government institutions in research & development activities for Alzheimer’s diseases. According to Alzheimer’s Association, an estimated of 5.7 millions of United States population combining all the age groups is living with Alzheimer’s dementia in the year 2018. Moreover, Asia pacific is anticipated to be the fastest growing region during the forecast period (2019-2026). Government’s influence to the healthcare sector and rising number neuro-specialty clinics in numerous hospitals are the major factor boosting the market growth.
Some of the major players of the market are Alpha Omega Ltd. (Germany), Agilent Technologies (United States), Bruker (United States), Fonar Corporation (United States), GE Healthcare (United States), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Hologic, Inc. (United States), Neusoft Medical Systems Co., Ltd. (United States), Roche Diagnostics (Switzerland) and Others. These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. For instance; For instance; in 2018, Brain Vision Solutions launched a high-density wireless EEG solution LiveAmp 64.
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Neurodiagnostics Market
2.1.1. Global Neurodiagnostics Market, by Application, 2018 (US$ Mn)
2.1.2. Global Neurodiagnostics Market, by Geography, 2018 (US$ Mn)
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increasing prevalence of neurological diseases
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing adoption of novel diagnostic technologies
3.2.2. Market Restraints
3.2.2.1. High Cost of Treatment
3.2.2.2. Lack of Trained and Skilled Professionals
3.2.3. Market Opportunities
3.2.3.1. Increasing Patient Base in Emerging Economies
3.2.3.2. Innovative product development
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Neurodiagnostics Market, by Application
4.1. Overview
4.1.1. Global Neurodiagnostics Market Value Share, by Application, 2018 & 2026 (Value, %)
4.1.2. Global Neurodiagnostics Market, by Application, 2019-2026 (US$ Mn)
4.2. In Vitro Diagnostics
4.2.1. Global Neurodiagnostics Market for In Vitro Diagnostics, 2019-2026 (US$ Mn)
4.2.2. Global Neurodiagnostics Market for In Vitro Diagnostics, by Region 2019-2026 (US$ Mn)
4.3. Neuroinformatics
4.3.1. Global Neurodiagnostics Market for Neuroinformatics, 2019-2026 (US$ Mn)
4.3.2. Global Neurodiagnostics Market for Neuroinformatics, by Region 2019-2026 (US$ Mn)
4.4. Neuroimaging
4.4.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
4.4.2. Global Neurodiagnostics Market for Neuroimaging, 2019-2026 (US$ Mn)
4.4.3. Global Neurodiagnostics Market for Neuroimaging, by Region 2019-2026 (US$ Mn)
4.4.4. Sub Segments
4.4.4.1. Magnetic Resonance Imaging
4.4.4.2. Computed Tomography
4.4.4.3. Nuclear Medicine Imaging
4.4.4.4. Electroencephalography
4.4.4.5. Near Infrared Spectroscopic Imaging
4.4.4.6. Voxel-based Morphometry
4.4.4.7. Magnetoencephalography
5. North America Neurodiagnostics Market Analysis
5.1. Overview
5.1.1. North America Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
5.1.2. North America Neurodiagnostics Market, by Product, 2019-2026 (US$ Mn)
5.1.3. North America Neurodiagnostics Market, by Country, 2019-2026 (US$ Mn)
5.1.3.1. United States
5.1.3.1.1. United States Neurodiagnostics Market 2019 – 2026 (US$ Mn)
5.1.3.2. Canada
5.1.3.2.1. Canada Neurodiagnostics Market 2019 – 2026 (US$ Mn)
6. Europe Neurodiagnostics Market Analysis
6.1. Overview
6.1.1. Europe Neurodiagnostics Market, by Application, 2019-2026 (US$ Mn)
6.1.2. Europe Neurodiagnostics Market, by Country/Region, 2019-2026 (US$ Mn)
6.1.2.1. UK
6.1.2.1.1. UK Neurodiagnostics Market 2019 – 2026 (US$ Mn)
6.1.2.2. Germany
6.1.2.2.1. Germany Neurodiagnostics Market 2019 – 2026 (US$ Mn)
6.1.2.3. France
6.1.2.3.1. France Neurodiagnostics Market 2019 – 2026 (US$ Mn)
6.1.2.4. Rest of Europe
6.1.2.4.1. Rest of Europe Neurodiagnostics Market 2019 – 2026 (US$ Mn)
7. Asia Pacific Neurodiagnostics Market Analysis
7.1. Overview
7.1.1. Asia Pacific Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
7.1.2. Asia Pacific Neurodiagnostics Market, by Country/Region, 2019-2026 (US$ Mn)
7.1.2.1. China
7.1.2.1.1. China Neurodiagnostics Market 2019 – 2026 (US$ Mn)
7.1.2.2. India
7.1.2.2.1. India Neurodiagnostics Market 2019 – 2026 (US$ Mn)
7.1.2.3. Japan
7.1.2.3.1. Japan Neurodiagnostics Market 2019 – 2026 (US$ Mn)
7.1.2.4. Rest of Asia Pacific
7.1.2.4.1. Rest of Asia Pacific Neurodiagnostics Market 2019 – 2026 (US$ Mn)
8. Rest of the World Neurodiagnostics Market Analysis
8.1. Overview
8.1.1. Rest of the World Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
8.1.2. Rest of the World Neurodiagnostics Market, by Country/Region, 2019 – 2026 (US$ Mn)
8.1.2.1. Latin America
8.1.2.1.1. Latin America Neurodiagnostics Market 2019 – 2026 (US$ Mn)
8.1.2.2. MENA
8.1.2.2.1. MENA Neurodiagnostics Market 2019 – 2026 (US$ Mn)
9. Company Profiles
9.1. Alpha Omega Ltd. (Germany)
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.3. Key Strategies
9.1.4. Key Conclusion
9.2. Agilent Technologies (United States)
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Key Strategies
9.2.4. Key Conclusion
9.3. Bruker (United States)
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Key Strategies
9.3.4. Key Conclusion
9.4. Fonar Corporation (United States)
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Key Strategies
9.4.4. Key Conclusion
9.5. GE Healthcare (United States)
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Key Strategies
9.5.4. Key Conclusion
9.6. Siemens Healthcare (Germany)
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Key Strategies
9.6.4. Key Conclusion
9.7. Hitachi Medical Corporation (Japan)
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Key Strategies
9.7.4. Key Conclusion
9.8. Hologic, Inc. (United States)
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Key Strategies
9.8.4. Key Conclusion
9.9. Neusoft Medical Systems Co., Ltd.(United States)
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Key Strategies
9.9.4. Key Conclusion
9.10. Roche Diagnostics (Switzerland)
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Key Strategies
9.10.4. Key Conclusion
1. Global Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
2. Global Neurodiagnostics Market for In-Vitro Diagnostics, by Region 2019-2026 (US$ Mn)
3. Global Neurodiagnostics Market for Neuroinformatics, by Region 2019-2026 (US$ Mn)
4. Global Neurodiagnostics Market for Neuroimaging Technologies, by Region 2019-2026 (US$ Mn)
5. Global Neurodiagnostics Market, by Geography, 2019-2026 (US$ Mn)
6. North America Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
7. North America Neurodiagnostics Market, by Country, 2019-2026 (US$ Mn)
8. Europe Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
9. Europe Neurodiagnostics Market, by Country/Region, 2019-2026 (US$ Mn)
10. Asia Pacific Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
11. Asia Pacific Neurodiagnostics Market, by Country/Region, 2019-2026 (US$ Mn)
12. Rest of the World Neurodiagnostics Market, by Technologies, 2019-2026 (US$ Mn)
13. Rest of the World Neurodiagnostics Market, by Country/Region, 2019 – 2026 (US$ Mn)
1. Global Neurodiagnostics Market, by Technologies, 2018 (US$ Mn)
2. Global Neurodiagnostics Market, by Geography, 2018 (US$ Mn)
3. Global Neurodiagnostics Market Value Share, by Technologies, 2018 & 2026 (Value, %)
4. Global Neurodiagnostics Market for In Vitro Diagnostics, 2019-2026 (US$ Mn)
5. Global Neurodiagnostics Market for Neuroinformatics, 2019-2026 (US$ Mn)
6. Global Neurodiagnostics Market for Neuroimaging Technologies, 2019-2026 (US$ Mn)
7. United States Neurodiagnostics Market 2019 – 2026 (US$ Mn)
8. Canada Neurodiagnostics Market 2019 – 2026 (US$ Mn)
9. UK Neurodiagnostics Market 2019 – 2026 (US$ Mn)
10. Germany Neurodiagnostics Market 2019 – 2026 (US$ Mn)
11. France Neurodiagnostics Market 2019 – 2026 (US$ Mn)
12. Rest of Europe Neurodiagnostics Market 2019 – 2026 (US$ Mn)
13. China Neurodiagnostics Market 2019 – 2026 (US$ Mn)
14. India Neurodiagnostics Market 2019 – 2026 (US$ Mn)
15. Japan Neurodiagnostics Market 2019 – 2026 (US$ Mn)
16. Rest of Asia Pacific Neurodiagnostics Market 2019 – 2026 (US$ Mn)
17. Latin America Neurodiagnostics Market 2019 – 2026 (US$ Mn)
18. MENA Neurodiagnostics Market 2019 – 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)